The page is the record's research on the issuer — no analyst, no rating, no view. # GENELUX Corp (NASDAQ: GNLX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is GENELUX Corp, listed on NASDAQ under ticker GNLX. Its ISIN is US36870H1032 and its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 60 filings in the twelve months from 2025-11-08 to 2026-11-08, across 30 filing days. Of these, 37 are directors' dealings, 9 are regulatory filings, 4 are corporate news, 3 are AGM/EGM notices, 3 are prospectuses, 3 are results, and 1 is a director change. The median gap between filing days is 8 days. The latest filing is dated 2026-11-05, is of type directors_dealings, and falls 3 days before the record date of 2026-11-08. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4,359 issuers. On 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days across 526 issuers. ## Auditor The auditor of record is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). Segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed on the record are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001231457.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/GNLX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/GNLX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/GNLX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp